Evidence map›Paper›PMID 38920749›Full record

ArticleCurrent oncology (Toronto, Ont.)2024

Correction: Gill et al. Report from the 24th Annual Western Canadian Gastrointestinal Cancer Consensus Conference on Colorectal Cancer, Richmond, British Columbia, 28-29, October 2022.

Sharlene Gill, Shahid Ahmed, Brady Anderson, Scott Berry, Howard Lim, Terry Phang, Ankur Sharma, Joao Paulo Solar Vasconcelos, Karamjit Gill, Mussawar Iqbal and 7 more

Abstract readPublished Erratum
PubMed Full text at PMC Publisher
In one paragraph

Article in Current oncology (Toronto, Ont.), 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Article
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

17 authors.

Sharlene GillBritish Columbia Cancer Agency, Vancouver, BC V5Z 4E6, Canada.ORCID 0000-0003-3306-3617
Shahid AhmedSaskatchewan Cancer Agency, Saskatoon, SK S4W 0G3, Canada.ORCID 0000-0002-2099-698X
Brady AndersonWestern Manitoba Cancer Center, Brandon, MB R7A 5M8, Canada.
Scott BerryDepartment of Oncology, Queen's University, Kingston, ON K7L 3N6, Canada.
Howard LimBritish Columbia Cancer Agency, Vancouver, BC V5Z 4E6, Canada.
Terry PhangDepartment of Surgery, University of British Columbia, Vancouver, BC V6T 1Z4, Canada.ORCID 0000-0001-6995-9285
Ankur SharmaCentral Alberta Cancer Centre, School of Medicine, University of Calgary Cumming, Red Deer, AB T4N 6R2, Canada.
Joao Paulo Solar VasconcelosBritish Columbia Cancer Agency, Vancouver, BC V5Z 4E6, Canada.
Karamjit GillBritish Columbia Cancer Agency, Vancouver, BC V5Z 4E6, Canada.
Mussawar IqbalAllan Blair Cancer Centre, Regina, SK S4T 7T1, Canada.
Keith TankelCross Cancer Institute, Edmonton, AB T6G 1Z2, Canada.
Theresa ChanBritish Columbia Cancer Agency, Surrey, BC V3V 1Z2, Canada.
Magdalena RecskyKelowna General Hospital, Kelowna, BC V1Y 1T2, Canada.
Jennifer NukBritish Columbia Cancer Hereditary Cancer Program, Victoria, BC V8R 6V5, Canada.
James PaulCancerCare Manitoba, University of Manitoba, Winnipeg, MB R3E 0V9, Canada.
Shazia MahmoodCross Cancer Institute, Edmonton, AB T6G 1Z2, Canada.
Karen MulderCross Cancer Institute, Edmonton, AB T6G 1Z2, Canada.ORCID 0000-0002-6832-0081

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Karen Mulder was not included as an author in the original publication [...].

Identifiers

PMID38920749
PMCPMC11202408

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.